Commentary: An all-access pass to transcatheter aortic valve replacement

[摘要] From the first-in-man description by Cribier and colleagues in 20021 to the most recently published guidelines on valvular heart disease in 2020,2 transcatheter aortic valve replacement (TAVR) has evolved from a niche procedure to a standard intervention. This has revolutionized the treatment of aortic stenosis, but also produced several unanswered questions with regard to valve durability, subclinical leaflet thrombosis, permanent pacemaker insertion with subsequent rehospitalization, the evolving role of TAVR in low-risk patients, and preparing future cardiac surgeons for practices that include transcatheter techniques.

[学科分类] 心脏病和心血管学